Regeneron

The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, U.S. September 17, 2020. Picture taken September 17, 2020. REUTERS/Brendan McDermid
Coronavirus chronicle

Regeneron's Covid antibody drug shows protection for up to 8 months

The therapy had previously shown an 81.4% risk reduction during the first month after administration

A computer image created by Nexu Science Communication together with Trinity College in Dublin, shows a model structurally representative of a betacoronavirus which is the type of virus linked to COVID-19, shared with Reuters on February 18, 2020. NEXU Science Communication/via REUTERS/File Photo
Coronavirus chronicle

AstraZeneca antibody cocktail succeeds in late-stage study to treat Covid-19

Vaccines being tested in laboratory. Photo: BSS/AFP
Coronavirus chronicle

Regeneron announces more positive results for Covid-19 treatment

The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, US September 17, 2020/ Reuters
Coronavirus chronicle

Regeneron antibodies in demand after Trump treatment, doctors seek more data

The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, US September 17, 2020/ Reuters
Coronavirus chronicle

Regeneron says its Covid-19 treatment reduces viral levels, improves symptoms

The ultrastructural morphology exhibited by the 2019 Novel Coronavirus, which was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China, is seen in an illustration released by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, US January 29, 2020/Reuters
Coronavirus chronicle

Regeneron's antibody drug added to UK Recovery trial of Covid treatments

Regeneron COVID-19 treatment enters final stage trials
Coronavirus chronicle

Regeneron COVID-19 treatment enters final stage trials

Drugmaker Regeneron working with US Health and Human Services to develop coronavirus treatment
World+Biz

Drugmaker Regeneron working with US Health and Human Services to develop coronavirus treatment